ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,203,000 | -59.4% | 153,445 | -42.2% | 0.00% | -60.0% |
| Q2 2015 | $15,274,000 | -30.6% | 265,385 | -23.3% | 0.01% | -37.5% |
| Q1 2015 | $22,019,000 | +56.7% | 345,819 | +51.9% | 0.01% | +60.0% |
| Q4 2014 | $14,054,000 | +61.8% | 227,644 | +1.8% | 0.01% | +66.7% |
| Q3 2014 | $8,686,000 | -20.2% | 223,690 | -29.2% | 0.00% | -25.0% |
| Q2 2014 | $10,878,000 | +53.1% | 315,755 | +92.0% | 0.00% | +33.3% |
| Q1 2014 | $7,107,000 | +75.0% | 164,481 | +61.4% | 0.00% | +50.0% |
| Q4 2013 | $4,060,000 | -25.8% | 101,930 | -30.1% | 0.00% | -33.3% |
| Q3 2013 | $5,472,000 | +38.8% | 145,761 | -0.7% | 0.00% | +50.0% |
| Q2 2013 | $3,943,000 | – | 146,719 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |